Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicamen Biotech Ltd. Proxy Solicitation & Information Statement 2022

Aug 3, 2022

61898_rns_2022-08-03_cbb63c24-ae06-49ea-919d-22cc439208e9.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

MEDICAMEN Biotech Limited

Regd. & Corp. Office: 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi - 110019 (INDIA)

Tel.: 011 - 47589500-51 (50 Lines}, E-mail: [email protected] Web: www.medicamen.com CIN No.: L74899DL 1993PLC056594

Ref: STEX/ EGM/ Intimation/ 2022-23

Date-03.08.2022

BSE Limited Floor 25, P J Towers Dalal Street Mumbai-400001

National Stock Exchange of India Ltd Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai - 400 051

BSE Code-531146

NSE Code: MEDICAMEQ

- Sub: Submission of Public Notice made in Newspaper for Extra Ordinary General Meeting

Dear Sir,

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclose herewith newspaper advertisement cutting for Extra- Ordinary General Meeting along with record dates and details of e-voting information, published in The Financial Express and Jansatta on 03.08.2022.

==> picture [163 x 90] intentionally omitted <==

Works: SP-1192, A & B Phase-IV, Industrial Area, Distt. Alwar, Bhiwadi - 301019 (Rajasthan), Works: Unit-I: Plot No.: 86 & 87. Sector-6A, Unit-II : Plot No. : 84 & 85, Sector-6A, IIE, SIDCUL, BHEL, Ranipur, Haridwar - 249403, (Uttrakhand)